Science Explorer Back to mapMap
Discussion
Hospital / health system · Norfolk · United States

Insight Therapeutics

insighttherapeutics.comROR OpenAlex
Research works
24
▼ 15% vs 2018-21
Citations
353
14.9 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
26%
world 40%
International
14%
world 18%
Insight Therapeutics

Not ranked overall: Insight Therapeutics is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Insight Therapeutics work in?

In all years, 72% of research at Insight Therapeutics is in Health Sciences, 12% in Life Sciences. Its largest fields are Medicine (60%), Health Professions (12%), Biochemistry, Genetics and Molecular Biology (10%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 17 fractional works · 72.4% of its workMedicine: 14 fractional works · 60.4% of its workEpidemiology: 4 fractional works · 16.5% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 12.0% of its workPulmonary and Respiratory Medicine: 2 fractional works · 9.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 5.1% of its workPsychiatry and Mental health: 1 fractional works · 4.7% of its workGeriatrics and Gerontology: 1 fractional works · 3.8% of its workOncology: 1 fractional works · 2.8% of its workInfectious Diseases: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workOphthalmology: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 3 fractional works · 11.6% of its workGeneral Health Professions: 2 fractional works · 10.0% of its workHealth Information Management: 0 fractional works · 0.7% of its workSpeech and Hearing: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.5% of its workSmall Animals: 0 fractional works · 0.5% of its workLife Sciences: 3 fractional works · 11.6% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 9.8% of its workMolecular Biology: 1 fractional works · 5.2% of its workCancer Research: 0 fractional works · 1.9% of its workCell Biology: 0 fractional works · 1.1% of its workEndocrinology: 0 fractional works · 0.8% of its workMolecular Medicine: 0 fractional works · 0.8% of its workBiophysics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 1.7% of its workImmunology: 0 fractional works · 0.8% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.5% of its workMicrobiology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 9.4% of its workPsychology: 1 fractional works · 3.5% of its workSocial Psychology: 0 fractional works · 2.1% of its workClinical Psychology: 0 fractional works · 1.4% of its workBusiness, Management and Accounting: 1 fractional works · 2.8% of its workStrategy and Management: 0 fractional works · 2.1% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 1.7% of its workEducation: 0 fractional works · 1.4% of its workHealth: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workArts and Humanities: 0 fractional works · 0.7% of its workHistory and Philosophy of Science: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.7% of its workManagement Science and Operations Research: 0 fractional works · 0.7% of its workPhysical Sciences: 2 fractional works · 6.6% of its workChemistry: 1 fractional works · 4.2% of its workInorganic Chemistry: 0 fractional works · 1.4% of its workOrganic Chemistry: 0 fractional works · 1.4% of its workSpectroscopy: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 0 fractional works · 1.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workAerospace Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.8% of its workEcology: 0 fractional works · 0.3% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workEnvironmental Engineering: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workRadiation: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.2% of its workALL ITS WORKInsightTherapeutics24fractional works, all years
Life Sciences12%Physical Sciences7%Health Sciences72%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1460.4%
    2. Health Professions311.6%
    3. Veterinary00.5%
    1. Biochemistry, Genetics and Molecular Biology29.8%
    2. Immunology and Microbiology01.7%
    1. Psychology13.5%
    2. Business, Management and Accounting12.8%
    3. Social Sciences01.7%
    4. Arts and Humanities00.7%
    5. Decision Sciences00.7%
    1. Chemistry14.2%
    2. Engineering01.1%
    3. Environmental Science00.8%
    4. Physics and Astronomy00.3%
    5. Mathematics00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.99× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.05× its world share, 0 worksImmunology and Micro…Engineering: 0.14× its world share, 0 worksEngineeringEnvironmental Science: 0.90× its world share, 0 worksEnvironmental ScienceHealth Professions: 3.58× its world share, 0 worksHealth ProfessionsMedicine: 3.63× its world share, 3 worksMedicineSocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.6×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Medicine3.63×3 works
  2. Health Professions3.58×0 works
  3. Immunology and Microbiology3.05×0 works
  4. Biochemistry, Genetics and Molecular Biology1.99×0 works
  5. Environmental Science0.90×0 works
  6. Engineering0.14×0 works
  7. Social Sciences0.05×0 works

Who are the top researchers at Insight Therapeutics?

Ranked on the quality score, Lisa Han and H. Edward Davidson lead among researchers whose main affiliation is Insight Therapeutics.

  1. 1 Lisa Han United States · #2,569,486 worldwide 470 citations · 54 works
  2. 2 H. Edward Davidson United States · #4,553,257 worldwide 1.3k citations · 126 works
All ranked researchers at Insight Therapeutics

What are the most cited papers from Insight Therapeutics?

The most cited paper from Insight Therapeutics is "Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer" (Shawn Hillier, Kevin P. Maresca, Frank J. Femia et al., 2009), with 319 citations. Next come "First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer" (209) and "Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial" (179).

Most cited papers
#PaperReleasedCitations
1 Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer Shawn Hillier, Kevin P. Maresca, Frank J. Femia et al. · Cancer Research Open access 26 Aug 2009 319
2 First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer John A. Barrett, Robert Edward Coleman, Stanley J. Goldsmith et al. · Journal of Nuclear Medicine Open access 9 Jan 2013 209
3 Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial Stefan Gravenstein, H. Edward Davidson, Monica Taljaard et al. · The Lancet Respiratory Medicine 20 Jul 2017 179
4 The Role of Copper in Disulfiram-Induced Toxicity and Radiosensitization of Cancer Cells Colin J. Rae, Mathias Tesson, John W. Babich et al. · Journal of Nuclear Medicine Open access 24 Apr 2013 87
5 Current Strategies for Management of Influenza in the Elderly Population Stefan Gravenstein, H. Edward Davidson · Clinical Infectious Diseases 15 Sep 2002 53
All 52 most cited papers, with filters and sorting

Which keywords describe research at Insight Therapeutics?

By fractional works in all years, weighted toward what it does more of than the world: PET Imaging, Targeted Therapy, Biomarkers, Cancer Treatment, Dosimetry, Radioimmunotherapy, Radiopharmaceuticals and Epidemiology.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Epidemiology3▲ 3.6×13 topics
  2. PET Imaging3▲ 53×2 topics
  3. Targeted Therapy3▲ 51×2 topics
  4. Biomarkers2▲ 17×4 topics
  5. Cancer Treatment2▲ 40×2 topics
  6. Dosimetry2▲ 111×2 topics
  7. Radioimmunotherapy2▲ 250×1 topic
  8. Radiopharmaceuticals2▲ 250×1 topic
  9. Quality of Care2▲ 113×3 topics
  10. Aging2▲ 14×3 topics
  11. Genetic Mutations2▲ 14×3 topics
  12. Immunotherapy2▲ 11×3 topics
  13. Nursing Home2▲ 199×1 topic
  14. Person-Centered Care2▲ 199×1 topic
  15. Clinical Trials2▲ 11×3 topics
  16. Pathogenesis2▲ 11×3 topics
  17. Respiratory2▲ 61×2 topics
  18. Pandemic1▲ 13×3 topics
  19. Prostate Cancer1▲ 41×2 topics
  20. Androgen Receptor1▲ 61×1 topic
  21. Genomic Profiling1▲ 57×1 topic
  22. Inflammation1▲ 2.3×5 topics
  23. Cancer Therapy1▲ 8.1×2 topics
  24. Drug Discovery1▲ 12×2 topics
  25. Influenza1▲ 107×1 topic
  26. Virus1▲ 43×1 topic
  27. Caregiver Burden1▲ 57×2 topics
  28. Tumor Hypoxia1▲ 53×2 topics
  29. Maternal Mental Health1▲ 120×1 topic
  30. Perinatal Depression1▲ 120×1 topic

Which research topics does Insight Therapeutics publish most on?

By volume in 2022-now: Geriatric Care and Nursing Homes, Influenza Virus Research Studies, Data-Driven Disease Surveillance and Herpesvirus Infections and Treatments.

Geriatric Care and Nursi…0Geriatric Care and Nursing Homes: 0 fractional worksInfluenza Virus Research…0Influenza Virus Research Studies: 0 fractional worksData-Driven Disease Surv…0Data-Driven Disease Surveillance: 0 fractional worksHerpesvirus Infections a…0Herpesvirus Infections and Treatments: 0 fractional worksRespiratory viral infections research: 0 fractional worksUrinary Tract Infections Management: 0 fractional worksCytomegalovirus and herp…0Cytomegalovirus and herpesvirus research: 0 fractional worksFacial Nerve Paralysis Treatment and Research: 0 fractional worksEscherichia coli research studies: 0 fractional worksAntibiotic Resistance in…0Antibiotic Resistance in Bacteria: 0 fractional works
General Health ProfessionsEpidemiologyNeurologyEndocrinology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Geriatric Care and Nursing Homes General Health Professions 0 works
  2. 2 Influenza Virus Research Studies Epidemiology 0 works
  3. 3 Data-Driven Disease Surveillance Epidemiology 0 works
  4. 4 Herpesvirus Infections and Treatments Epidemiology 0 works
  5. 5 Respiratory viral infections research Epidemiology 0 works
  6. 6 Urinary Tract Infections Management Epidemiology 0 works
  7. 7 Cytomegalovirus and herpesvirus research Epidemiology 0 works
  8. 8 Facial Nerve Paralysis Treatment and Research Neurology 0 works
  9. 9 Escherichia coli research studies Endocrinology 0 works
  10. 10 Antibiotic Resistance in Bacteria Molecular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.5%not open73.5%

World: 40% of research is openly available.

with international co-authors13.6%domestic only86.4%

World: 18% is written across borders.

How has Insight Therapeutics's research output changed?

Output in 2022-2025 was 15% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Insight Therapeutics as a percentage of every work published that year, 0.0000031% in 2024.

still counting0.000050%0.00010%0.00015%Insight Therapeutics0.000020% in 202520102020

Fractional works of Insight Therapeutics over all fractional works that year. How the balance of science has shifted.

Other research institutions in Norfolk

All research institutions in Norfolk

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Insight Therapeutics. Posts are plain text and can be reported.